S-1MEF: PACS Group Files for Additional Shares in S-1 Registration, Increasing Offering by $120 Million
Registration Statement
PACS Group, Inc. has filed a registration statement to increase the number of shares offered in its initial public offering by approximately $120.1 million.
Summary
- PACS Group, Inc. filed a Form S-1 registration statement on September 5, 2024, to register additional shares of common stock for its IPO.
- The filing is made under Rule 462(b) of the Securities Act of 1933 and increases the aggregate number of shares offered by 3,062,260.
- This includes 399,426 shares subject to the underwriters' option to purchase additional shares.
- The additional securities represent no more than 20% of the maximum aggregate offering price set forth in the original registration statement.
- The proposed maximum aggregate offering price for the additional shares is approximately $120.1 million.
- The filing fee for the additional registration is $17,731.55.
- The company's principal executive offices are located in Farmington, Utah, and its Chief Executive Officer is Jason Murray.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as the company is progressing with its IPO plans, indicating confidence in its business and market conditions. The increase in shares offered suggests potential strong demand.
Positives
- The company is proceeding with its IPO plans.
- The underwriters have an option to purchase additional shares, indicating potential demand.
- Ernst & Young LLP has provided consent for the incorporation by reference of their audit report.
Risks
- The registration statement is subject to SEC review and may be subject to change.
- Market conditions could impact the success of the IPO.
Future Outlook
The company intends to commence the proposed sale to the public as soon as practicable after the registration statement is declared effective.
Industry Context
This announcement indicates PACS Group's continued progress towards becoming a publicly traded company, reflecting investor interest in the healthcare services sector.
Stakeholder Impact
- Shareholders: Potential dilution of existing shares.
- Employees: Potential for increased company value and growth.
- Customers: No immediate impact expected.
- Suppliers: No immediate impact expected.
- Creditors: No immediate impact expected.
Next Steps
- The SEC will review the registration statement.
- The company will proceed with the IPO after the registration statement is declared effective.
Key Dates
| Date | Description |
|---|---|
| March 13, 2024 | Date of Ernst & Young LLP's audit report (except for the retroactive effect of the stock split). |
| April 1, 2024 | Date for the retroactive effect of the 1-for-6,436.1693 stock split as described in the fourth paragraph of Note 17. |
| August 30, 2024 | Date used to estimate the offering price, based on the average of the high and low reported trading prices of the common stock as reported on the New York Stock Exchange. |
| September 3, 2024 | Date of Prior Registration Statement (File No. 333-281904). |
| September 5, 2024 | Date of the current S-1MEF filing and the date the Prior Registration Statement was declared effective. |
Keywords
IPO, registration statement, PACS Group, securities, offering, common stock, S-1, Rule 462(b)
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.